ClinicalTrials.Veeva

Menu

Ultrasound Guided Intercostobrachial Nerve Block

D

Dr. Christoph Ilies

Status

Completed

Conditions

Anaesthesia

Treatments

Drug: 10ml ropivacain 0.5%

Study type

Interventional

Funder types

Other

Identifiers

NCT02805582
iCobra 2016

Details and patient eligibility

About

The intercostobrachial nerve underlies many anatomical variations. For surgery of the upper arm the axilla is usually not anaesthetized by a brachial plexus block, which therefore needs to be completed by an intercostobrachial nerve block. The optimal access for an ultrasound guided block of the intercostobrachial nerve is not yet known. The investigators compare a proximal and a more distal approach to the nerve referred to onset time, sensory blocked area and duration.

Full description

The participants will be randomized into two groups:

Group one receives a modified PECS 2 (thoracic wall) block above the second intercostal space with injection between the Musculus serratus anterior and Musculus pectoralis minor.

Group 2 receives a subpectoral block under the pectoralis major muscle at the medial boarder of the axillary triangle.

Enrollment

29 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients planned for vascular access surgery of the upper arm
  • surgery planned under regional anaesthesia

Exclusion criteria

  • patients refusal
  • age under 18
  • allergy against local anaesthetics
  • polyneuropathies

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

29 participants in 2 patient groups

Anterior musculus serratus block
Active Comparator group
Description:
Proximal nerve block above the second intercostal space between Musculus serratus anterior and Musculus pectoralis minor. Intervention: 10ml ropivacain 0.5%
Treatment:
Drug: 10ml ropivacain 0.5%
Subpectoral block
Active Comparator group
Description:
Distal nerve block under the Musculus pectoralis major at the medial border of the axillary triangle. Intervention: 10ml ropivacain 0.5%
Treatment:
Drug: 10ml ropivacain 0.5%

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems